Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details Narrative)

v3.23.1
Income Taxes (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2018
Operating Loss Carryforwards [Line Items]      
Deferred tax assets $ 37,398,000 $ 27,244,000  
Deferred tax assets valuation allowance 37,398,000 27,244,000  
Valuation allowance 10,200,000    
Operating loss 134,100,000 119,600,000  
Research and development costs 4,900,000    
Accumulated gross amount 8,800,000    
Operating loss utilization limit   3,700,000  
Deferred Federal Income Tax Expense (Benefit) 26,875,000 18,420,000  
Deferred State and Local Income Tax Expense (Benefit) $ 25,464,000 17,009,000  
Expire date, description begin to expire after 2036 through 2042    
Deferred Foreign Income Tax Expense (Benefit) $ 81,794,000 84,148,000  
ISRAEL      
Operating Loss Carryforwards [Line Items]      
Deferred Foreign Income Tax Expense (Benefit) 81,794,000    
[custom:DeferredForeignIncomeTaxExpenseBenefitAvailableUse] 38,100,000    
Federal [Member]      
Operating Loss Carryforwards [Line Items]      
Deferred Federal Income Tax Expense (Benefit) $ 3,300,000   $ 23,575,000,000
State [Member]      
Operating Loss Carryforwards [Line Items]      
Deferred State and Local Income Tax Expense (Benefit)   $ 25,464,000